Oral Ondansetron Administration to Nondehydrated Children With Diarrhea and Associated Vomiting in Emergency Departments in Pakistan: A Randomized Controlled Trial.

Journal Information

Full Title: Ann Emerg Med

Abbreviation: Ann Emerg Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Emergency Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Funding for this study was provided by the Bill & Melinda Gates Foundation (grant OPP1058793), the Thrasher Research Fund (award 10025), and the Alberta Children’s Hospital Foundation. Dr. Freedman is the Alberta Children’s Hospital Foundation Professor in Child Health and Wellness. He reports receiving in-kind support in the form of provision of study drug and placebo by GlaxoSmithKline Inc."

Evidence found in paper:

"Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org ). Funding for this study was provided by the Bill & Melinda Gates Foundation (grant OPP1058793), the Thrasher Research Fund (award 10025), and the Alberta Children’s Hospital Foundation. Dr. Freedman is the Alberta Children’s Hospital Foundation Professor in Child Health and Wellness. He reports receiving in-kind support in the form of provision of study drug and placebo by GlaxoSmithKline Inc."

Evidence found in paper:

"Trial registration number: NCT01870635"

Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025